Search results
Author(s):
Rosana González Mesa
,
Aaron Álvarez Amigo
,
Alejandro Gullón de la Roza
,
et al
Added:
5 days ago
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
1 year ago
Author(s):
Devi Nair
Added:
2 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Author(s):
Vivek Reddy
Added:
2 months ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,…
View more
The Hybrid Approach in CAD with Restore® DEB
Video Series
Author(s):
Cristina Helguera Amezua
,
Laura Pérez Bacigalupe
,
Diego Manuel de la Eranueva
,
et al
Added:
5 days ago
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
5 months ago
Original Research
Author(s):
Julien Dreyfus
Added:
11 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating…
View more
Author(s):
Nils Krüger
Added:
5 months ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients…
View more
Author(s):
Raj Makkar
Added:
5 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid…
View more